Figure 3.
![Figure 3. Age and CR rate of biCEBPACCSpos, biCEBPACCSneg, and moCEBPA patients. (A) Age of biCEBPACCSneg (median = 48), biCEBPACCSpos (median = 66), and moCEBPA (median = 62) patients. Scatter dot plot, median with interquartile range. (B) The CR rate was significantly higher in biCEBPACCSneg patients (91% [20/22]) than biCEBPACCSpos (61% [14/23]; P = .035) and moCEBPA patients (P = .027).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/2/20/10.1182_bloodadvances.2018016840/4/advances016840f3.png?Expires=1724921743&Signature=F-PUKmqfG800ph889vxv960J9hOWp8SVZG1GdM-408Y4HFSVaYVsm~V4Kydn7A7p8wfTdtvFs9dhtoNRzSGnxr291RUDiVQs45-N4vhR7Z9Rvx~9ssM-29bnoySqWDvXhH0O1PoH5CyT5APFRkxtsdp96I8Ewqwnv-cNTQisbVURytzSq-AFxywnrur-OuNe8f7fyGr8-xFOAJSrEllFb5-iORD25e-bOFvVxThRJ3rb5zpc8pOsAYhgnp3VEDUp0X9LIhoqiFlyfnami7wcK8VNjk5WNS~QI~gCIqHdhUpFIPwtDj0uhBSf-Bq0bRL9zfkoSSf2L-~i9AIGXeEoxA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Age and CR rate of biCEBPACCSpos, biCEBPACCSneg, and moCEBPA patients. (A) Age of biCEBPACCSneg (median = 48), biCEBPACCSpos (median = 66), and moCEBPA (median = 62) patients. Scatter dot plot, median with interquartile range. (B) The CR rate was significantly higher in biCEBPACCSneg patients (91% [20/22]) than biCEBPACCSpos (61% [14/23]; P = .035) and moCEBPA patients (P = .027).